Mediphage is a biotech company developing non-viral safe and redosable gene therapies. ministring DNA (msDNA), which is Mediphage’s flagship technology, is a versatile linear covalently closed (LCC) DNA construct that can accommodate large transgenes (> 4.7 kb) and address various applications. The company is evaluating the therapeutic potential of its non-viral platform technology in a number of indications internally and through external collaborations.
Company Details
- Employees
- 10
- Founded
- -
- Address
- 661 University Avenue, 1300,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- mediphage.bio
- Keywords
- gene therapy, non-viral vectors, biotechnology, DNA Vaccine, CNS, Retina, Hemophilia, gene editing, plasmids for AAV manufacturing.
- HQ
- Toronto, Ontario
Mediphage Questions
Mediphage's website is mediphage.bio
Mediphage's LinkedIn profile is https://ca.linkedin.com/company/mediphage
Mediphage has
10 employees.
View email and phone details for 10
employees at Mediphage.
Mediphage's industry is
Biotechnology Research
Mediphage's top competitors are
Proxai,
Cerecura Nanotherapeutics,
Seragene Therapeutics,
Noa Therapeutics,
Kapoose Creek Bio,
Neiges Biotechnologies,
Epiloid Biotechnology,
Htuo Biosciences,
Phinc. Modeling,
Ability Biotherapeutics.
Mediphage's categories are Biotechnology Research
Mediphage's founding year is 2016
